Insights

Sepsis Focus Target the sepsis diagnostic workflow as a flagship offering, emphasizing rapid host response profiling, pathogen ID with resistance detection, and culture-free phenotyping to shorten clinical decision windows and improve antimicrobial stewardship.

OEM Collaboration Position the platform as an enabling layer for OEM diagnostics to reduce system cost and complexity while expanding multiplexing capabilities across infectious diseases, chronic diseases, and precision health AI applications.

Multi-Omic Advantage Highlight the single-sample, high-plex electrochemical architecture that replaces optical and thermal-cycle workflows, enabling scalable, cost-effective assays for hospitals, point-of-care, and high-throughput labs.

Clinical Partnerships Leverage existing collaboration with Mount Sinai and active engagement with clinical partners to accelerate pilots, generate real-world data, and attract funding and strategic investors.

Funding & Growth Target strategic funding rounds and grants by showcasing early revenue potential, global scalability, and a defensible IP portfolio to attract biopharma, diagnostics OEMs, and public health segments.

Similar companies to Guanine Inc

Guanine Inc Tech Stack

Guanine Inc uses 8 technology products and services including Snowplow, Duda, Weebly, and more. Explore Guanine Inc's tech stack below.

  • Analytics
  • Content Management System
  • Content Management System
  • RequireJS
    Javascript Frameworks
  • Moment.js
    Javascript Libraries
  • Cloudflare Bot Management
    Security
  • Apache
    Web Servers

Guanine Inc's Email Address Formats

Guanine Inc uses at least 1 email format:
Guanine Inc Email FormatsExamplePercentage
First.Last@guanineinc.comJohn.Doe@guanineinc.com
100%

Frequently Asked Questions

What is Guanine Inc's official website and social media links?

Minus sign iconPlus sign icon
Guanine Inc's official website is guanineinc.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Guanine Inc generate?

Minus sign iconPlus sign icon
As of October 2026, Guanine Inc's annual revenue is estimated to be <$1M.

What is Guanine Inc's SIC code and NAICS code?

Minus sign iconPlus sign icon
Guanine Inc's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Guanine Inc have currently?

Minus sign iconPlus sign icon
As of October 2026, Guanine Inc has approximately 2 employees across 1 continents, including North America. Key team members include Vice President, Research & Development: G. P. Explore Guanine Inc's employee directory with LeadIQ.

What industry does Guanine Inc belong to?

Minus sign iconPlus sign icon
Guanine Inc operates in the Biotechnology Research industry.

What technology does Guanine Inc use?

Minus sign iconPlus sign icon
Guanine Inc's tech stack includes Snowplow, Duda, Weebly, Microsoft 365, RequireJS, Moment.js, Cloudflare Bot Management and Apache.

What is Guanine Inc's email format?

Minus sign iconPlus sign icon
Guanine Inc's email format typically follows the pattern of First.Last@guanineinc.com. Find more Guanine Inc email formats with LeadIQ.

How much funding has Guanine Inc raised to date?

Minus sign iconPlus sign icon
As of October 2026, Guanine Inc has raised $250K in funding. The last funding round occurred on May 19, 2022 for $250K.

When was Guanine Inc founded?

Minus sign iconPlus sign icon
Guanine Inc was founded in 2013.
Guanine Inc logo

Guanine Inc

Biotechnology ResearchNew York, United States2-10 Employees

Guanine Inc is a biotechnology research company based in Rensselaer, New York. It is developing a universal electrochemical sensing platform that seeks to replace fragmented diagnostic methods with a single, scalable system capable of high-plex, multi-omic measurement from a single sample. The technology operates without optics, thermal cycling, or complex instrumentation, enabling rapid and cost-effective quantification of proteins, metabolites, nucleic acids, and functional drug responses, with plans to scale from point-of-care and hospital settings to OEM and high-throughput laboratory formats.

The company's initial clinical focus is sepsis, with a workflow under development that aims to deliver host response profiling in about 20 minutes, pathogen identification and antimicrobial resistance detection in about 60 minutes, and culture-free phenotyping in about 90 minutes. Guanine leverages deep electrochemical biosensing expertise and has a collaboration with Mount Sinai Health Systems, while actively engaging clinical partners and OEMs to scale the platform globally. OEM partners can deploy the platform to accelerate assay development, reduce system cost and complexity, and broaden multiplexing across infectious disease, chronic diseases, pharmaceutical diagnostics, and precision health AI applications.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
2-10

Section iconFunding & Financials

  • $250K

    Guanine Inc has raised a total of $250K of funding over 1 rounds. Their latest funding round was raised on May 19, 2022 in the amount of $250K as a Seed.

  • <$1M

    Guanine Inc's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.